科研之友ScholarMate
免费注册
首页 论文 论文详情
赞 收藏 引用

Advantages of prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: An open-label, randomized, multicenter phase Ⅲ study.

作者：Jie, Xie; Jun, Cao; Zhonghua, Wang; Biyun, Wang; Sheng, Zhang; Leiping, Wang; Jian, Zhang; Zhonghua, Tao; Ting, Li; JinFeng, Zhang; Xi-Chun, Hu
来源：Journal of Clinical Oncology, 2016, 34(15_suppl): e14043-e14043.
DOI：10.1200/jco.2016.34.15_suppl.e14043

全文

全文

访问全文
收藏 分享 被引 浏览
更新时间：2021-03-22 06:43